학술논문

Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinoma
Document Type
Article
Source
In Annals of Oncology September 2021 32(9):1127-1136
Subject
Gastrointestinal tumors
Language
ISSN
0923-7534